Table: Kyorin Holdings -2018/19 group results

Kyorin Pharmaceutical

13/05/2019 06:30

May 13 (Reuters)- 
          Kyorin Holdings Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          113.62          110.64         114.10        52.10    
               (+2.7 pct)      (-4.1 pct)     (+0.4 pct)    (+3.5 pct) 
  Operating        8.97            8.82           9.10         2.30    
               (+1.7 pct)      (-15.3 pct)    (+1.4 pct)   (-19.4 pct) 
  Recurring        9.44            9.35           9.60         2.50    
               (+1.0 pct)      (-14.1 pct)    (+1.7 pct)   (-21.5 pct) 
  Net
  Net              6.87            6.57           7.10         1.90    
               (+4.5 pct)      (-10.0 pct)    (+3.4 pct)   (-14.3 pct) 
  EPS          104.68 yen       89.28 yen     123.94 yen    33.17 yen  
  Ann Div       75.00 yen       58.00 yen      75.00 yen               
  -Q2 Div       30.00 yen       20.00 yen      30.00 yen               
  -Q4 Div       45.00 yen       38.00 yen      45.00 yen               
  
  NOTE - Kyorin Holdings Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T